A molecular diagnostics company developed a blood test to support treatment selection for patients with advanced non-small cell lung cancer (NSCLC). While many patients with EGFR-mutated, PDL-1 expressing NSCLC respond to immune checkpoint inhibitors (ICIS), many do not. An unmet medical need existed for a more precise test to determine which patients with this tumor type would respond to ICIS. The client's blood test purported to predict patient response to ICIS.

Read the case study

Read the white paper

Download

Achieve your boldest ambitions

Explore how Datavant can be your health data logistics partner.

Datavant makes the world’s health data secure, accessible, and usable. Datavant is a data logistics company for healthcare whose products and solutions enable organizations to move and connect data securely.

Through proprietary technology, the world's most robust healthcare network, and value-added services we protect, connect, and deliver the world's health data. Datavant enables more than 60 million healthcare records to move between thousands of organizations, more than 70,000 hospitals and clinics, 70% of the 100 largest health systems, and an ecosystem of 500+ real-world data partners.

Info@datavant.com